← Open Payments lookup

AMANDA SPEICHER: Open Payments

NPI 1376843011 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,900 in 94 payments from 11 companies in 2025. Trend: 2023 $1,310 · 2024 $1,087 · 2025 $1,900

Food & beverage: $1,797Education: $103
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$281
Teva Pharmaceuticals USA, Inc.12$278
Otsuka America Pharmaceutical, Inc.14$270
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$248
ABBVIE INC.12$223
Vanda Pharmaceuticals Inc.9$193
Lundbeck LLC8$152
Alkermes, Inc.4$93
Axsome Therapeutics, Inc.3$70
Takeda Pharmaceuticals U.S.A., Inc.3$50

Products named: REXULTI, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, AUSTEDO XR, ARISTADA, Auvelity.

Industry payments across CT — which companies pay providers there.